| Literature DB >> 32910923 |
E Daudén Tello1, J Alonso Suárez2, E Beltrán Catalán3, C Blasco Maldonado4, M C Herrero Manso5, A Jiménez Morales6, I Marín-Jiménez7, M D Martín-Arranz8, A García-Merino9, J Porta Etessam10, M A Rodríguez-Sagrado11, J Rosas Gómez de Salazar12, E Trujillo Martín13, L Salgado-Boquete14.
Abstract
We present a series of general and specific recommendations based on pathophysiologic considerations for managing the most common adverse effects of apremilast that lead to treatment discontinuation: diarrhea, nausea, and headache. The recommendations are based on a review of the literature and the experience of a multidisciplinary team of 14 experts including dermatologists, rheumatologists, neurologists, gastroenterologists, pharmacists, and nurses. We propose a series of simple algorithms that include clinical actions and suggestions for pharmacologic treatment. The adverse effects of apremilast can be managed from a multidisciplinary approach. The purpose of optimizing management is to bring clinical benefits to patients.Entities:
Keywords: Adverse effects; Apremilast; Cefalea; Diarrea; Diarrhea; Efectos adversos; Headache; Nausea; Náuseas; Psoriasis
Mesh:
Substances:
Year: 2020 PMID: 32910923 DOI: 10.1016/j.ad.2020.08.007
Source DB: PubMed Journal: Actas Dermosifiliogr (Engl Ed) ISSN: 2173-5778